无创心脏血液动力学和体液含量系统(NICaS)参数能否预测急诊科白种人和亚裔患者的急性心力衰竭预后?

IF 2.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Advances in medical sciences Pub Date : 2024-02-21 DOI:10.1016/j.advms.2024.02.005
Muhammad Anshory , Win Sen Kuan , M. Saifur Rohman , Yoga Waranugraha , Putri Annisa Kamila , Agustin Iskandar , Hani Susianti , Ying Wei Yau , Crystal Harn Wei Soh , Khalid Mohammed Ali , Mui Teng Chua , Salvatore Di Somma
{"title":"无创心脏血液动力学和体液含量系统(NICaS)参数能否预测急诊科白种人和亚裔患者的急性心力衰竭预后?","authors":"Muhammad Anshory ,&nbsp;Win Sen Kuan ,&nbsp;M. Saifur Rohman ,&nbsp;Yoga Waranugraha ,&nbsp;Putri Annisa Kamila ,&nbsp;Agustin Iskandar ,&nbsp;Hani Susianti ,&nbsp;Ying Wei Yau ,&nbsp;Crystal Harn Wei Soh ,&nbsp;Khalid Mohammed Ali ,&nbsp;Mui Teng Chua ,&nbsp;Salvatore Di Somma","doi":"10.1016/j.advms.2024.02.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>Acute heart failure (AHF) is a serious condition that requires prompt diagnosis and management. To optimize patient care, clinicians need a reliable, non-invasive method to assess hemodynamic parameters and total body congestion. Currently, no standardized technology is widely used for this purpose. However, NICaS technology, which measures hemodynamic parameters based on regional bioimpedance, has shown promise in monitoring AHF patients in a non-invasive and reliable manner. In this study, researchers aimed to evaluate the usefulness of NICaS technology in predicting patients' outcome in Caucasian and Asian AHF patients presenting to the emergency department (ED).</p></div><div><h3>Patients and methods</h3><p>The study included 40 Caucasian patients from Italy (group A) and 71 Asian patients from Indonesia and Singapore (group B) with a diagnosis of AHF in the ED. The study compared data from NICaS parameters, clinical findings, laboratory, and radiological results with short-term events.</p></div><div><h3>Results</h3><p>In group A, NICaS data at ED arrival significantly predicted 30-day cardiovascular mortality and rehospitalization. At discharge, a value of cardiac output obtained using NICaS was a significant predictor for 30-day rehospitalization. In group B, NICaS variables, total peripheral resistance index on admission and during 48–72 ​h had prominent AUC compared to clinical congestion score and NT-proBNP in predicting mortality and rehospitalization.</p></div><div><h3>Conclusions</h3><p>The results indicate that NICaS technology offers a simple, non-invasive, and reliable method of assessing cardiac hemodynamics and congestion in AHF patients. These measurements may enhance diagnosis, tailor management plans, stratify risk, and predict outcomes in both Caucasian and Asian patients.</p></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"69 1","pages":"Pages 81-89"},"PeriodicalIF":2.5000,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1896112624000099/pdfft?md5=780b671136fc56065ddc5a1e340d8ff7&pid=1-s2.0-S1896112624000099-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Can non-invasive cardiac hemodynamics and fluid content system (NICaS) parameters predict Acute Heart Failure outcomes in Caucasian and Asian patients in the emergency department?\",\"authors\":\"Muhammad Anshory ,&nbsp;Win Sen Kuan ,&nbsp;M. Saifur Rohman ,&nbsp;Yoga Waranugraha ,&nbsp;Putri Annisa Kamila ,&nbsp;Agustin Iskandar ,&nbsp;Hani Susianti ,&nbsp;Ying Wei Yau ,&nbsp;Crystal Harn Wei Soh ,&nbsp;Khalid Mohammed Ali ,&nbsp;Mui Teng Chua ,&nbsp;Salvatore Di Somma\",\"doi\":\"10.1016/j.advms.2024.02.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>Acute heart failure (AHF) is a serious condition that requires prompt diagnosis and management. To optimize patient care, clinicians need a reliable, non-invasive method to assess hemodynamic parameters and total body congestion. Currently, no standardized technology is widely used for this purpose. However, NICaS technology, which measures hemodynamic parameters based on regional bioimpedance, has shown promise in monitoring AHF patients in a non-invasive and reliable manner. In this study, researchers aimed to evaluate the usefulness of NICaS technology in predicting patients' outcome in Caucasian and Asian AHF patients presenting to the emergency department (ED).</p></div><div><h3>Patients and methods</h3><p>The study included 40 Caucasian patients from Italy (group A) and 71 Asian patients from Indonesia and Singapore (group B) with a diagnosis of AHF in the ED. The study compared data from NICaS parameters, clinical findings, laboratory, and radiological results with short-term events.</p></div><div><h3>Results</h3><p>In group A, NICaS data at ED arrival significantly predicted 30-day cardiovascular mortality and rehospitalization. At discharge, a value of cardiac output obtained using NICaS was a significant predictor for 30-day rehospitalization. In group B, NICaS variables, total peripheral resistance index on admission and during 48–72 ​h had prominent AUC compared to clinical congestion score and NT-proBNP in predicting mortality and rehospitalization.</p></div><div><h3>Conclusions</h3><p>The results indicate that NICaS technology offers a simple, non-invasive, and reliable method of assessing cardiac hemodynamics and congestion in AHF patients. These measurements may enhance diagnosis, tailor management plans, stratify risk, and predict outcomes in both Caucasian and Asian patients.</p></div>\",\"PeriodicalId\":7347,\"journal\":{\"name\":\"Advances in medical sciences\",\"volume\":\"69 1\",\"pages\":\"Pages 81-89\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-02-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1896112624000099/pdfft?md5=780b671136fc56065ddc5a1e340d8ff7&pid=1-s2.0-S1896112624000099-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in medical sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1896112624000099\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in medical sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1896112624000099","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

摘要

目的急性心力衰竭(AHF)是一种需要及时诊断和治疗的严重疾病。为了优化患者护理,临床医生需要一种可靠、无创的方法来评估血液动力学参数和全身充血情况。目前,还没有标准化的技术被广泛应用于这一目的。然而,基于区域生物阻抗测量血液动力学参数的 NICaS 技术已显示出以无创且可靠的方式监测 AHF 患者的前景。在这项研究中,研究人员旨在评估 NICaS 技术在预测急诊科(ED)白种人和亚裔 AHF 患者的预后方面的实用性。研究对象包括 40 名来自意大利的白种人患者(A 组)以及 71 名来自印度尼西亚和新加坡的亚裔患者(B 组),他们都被诊断为急诊科 AHF 患者。研究将 NICaS 参数、临床发现、实验室和放射学结果等数据与短期事件进行了比较。结果在 A 组中,急诊室到达时的 NICaS 数据可显著预测 30 天的心血管死亡率和再住院率。出院时,使用 NICaS 获得的心输出量值可显著预测 30 天的再住院率。在 B 组中,NICaS 变量、入院时和 48-72 小时内的总外周阻力指数与临床充血评分和 NT-proBNP 相比,在预测死亡率和再住院方面具有更显著的 AUC。这些测量结果可帮助白种人和亚裔患者加强诊断、定制管理计划、进行风险分层并预测预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Can non-invasive cardiac hemodynamics and fluid content system (NICaS) parameters predict Acute Heart Failure outcomes in Caucasian and Asian patients in the emergency department?

Purpose

Acute heart failure (AHF) is a serious condition that requires prompt diagnosis and management. To optimize patient care, clinicians need a reliable, non-invasive method to assess hemodynamic parameters and total body congestion. Currently, no standardized technology is widely used for this purpose. However, NICaS technology, which measures hemodynamic parameters based on regional bioimpedance, has shown promise in monitoring AHF patients in a non-invasive and reliable manner. In this study, researchers aimed to evaluate the usefulness of NICaS technology in predicting patients' outcome in Caucasian and Asian AHF patients presenting to the emergency department (ED).

Patients and methods

The study included 40 Caucasian patients from Italy (group A) and 71 Asian patients from Indonesia and Singapore (group B) with a diagnosis of AHF in the ED. The study compared data from NICaS parameters, clinical findings, laboratory, and radiological results with short-term events.

Results

In group A, NICaS data at ED arrival significantly predicted 30-day cardiovascular mortality and rehospitalization. At discharge, a value of cardiac output obtained using NICaS was a significant predictor for 30-day rehospitalization. In group B, NICaS variables, total peripheral resistance index on admission and during 48–72 ​h had prominent AUC compared to clinical congestion score and NT-proBNP in predicting mortality and rehospitalization.

Conclusions

The results indicate that NICaS technology offers a simple, non-invasive, and reliable method of assessing cardiac hemodynamics and congestion in AHF patients. These measurements may enhance diagnosis, tailor management plans, stratify risk, and predict outcomes in both Caucasian and Asian patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Advances in medical sciences
Advances in medical sciences 医学-医学:研究与实验
CiteScore
5.00
自引率
0.00%
发文量
53
审稿时长
25 days
期刊介绍: Advances in Medical Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in life sciences, preclinical and clinical medicine, and related disciplines. The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments. Advances in Medical Sciences publishes articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications Advances in Medical Sciences also stresses the importance of pharmaceutical sciences as a rapidly and ever expanding area of research on drug design, development, action and evaluation contributing significantly to a variety of scientific disciplines. The journal welcomes submissions from the following disciplines: General and internal medicine, Cancer research, Genetics, Endocrinology, Gastroenterology, Cardiology and Cardiovascular Medicine, Immunology and Allergy, Pathology and Forensic Medicine, Cell and molecular Biology, Haematology, Biochemistry, Clinical and Experimental Pathology.
期刊最新文献
Targeting treatment resistance in cervical cancer: A new avenue for senolytic therapies. Recurrent hepatocellular carcinoma is associated with the enrichment of MYC targets gene sets, elevated high confidence deleterious mutations and alternative splicing of DDB2 and BRCA1 transcripts Knockout of histone deacetylase 8 gene in breast cancer cells may alter the expression pattern of the signaling molecules Combination therapy of placenta-derived mesenchymal stem cells and artificial dermal scaffold promotes full-thickness skin defects vascularization in rat animal model Enhancing the accuracy and effectiveness of diagnosis of spontaneous bacterial peritonitis in cirrhotic patients: A machine learning approach utilizing clinical and laboratory data
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1